Pharmacotherapy of obstructive sleep apnea

Expert Opinion on Pharmacotherapy

Volumn 13, Issue 6, 2012, Pages 841-857

  Lin, Chia Mo ^a,b   Huang, Yu Shu ^c   Guilleminault, Christian ^d  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d STANFORD UNIVERSITY   (United States)

Author keywords

CPAP; Pharmacotherapy; Sleep apnea; Treatment

Indexed keywords

6 (4 CARBOXYPHENYLTHIO) 5 HYDROXY 7,9,11,14 ICOSATETRAENOIC ACID; ACETAZOLAMIDE; AMINOPHYLLINE; ANTIALLERGIC AGENT; ARMODAFINIL; CLONIDINE; DONEPEZIL; DOXAPRAM; ESTROGEN; ETANERCEPT; FLUNITRAZEPAM; FLUOXETINE; FLUTAMIDE; GLUTAMATE RECEPTOR ANTAGONIST; MEDROXYPROGESTERONE; MIRTAZAPINE; MODAFINIL; NICOTINIC AGENT; OCTREOTIDE; OPIATE ANTAGONIST; PAROXETINE; PHYSOSTIGMINE; PROGESTERONE; PROTRIPTYLINE; SEROTONIN AGONIST; SPIRONOLACTONE; STEROID; THEOPHYLLINE; THYROID HORMONE; TRIAZOLAM; UNINDEXED DRUG;

ACROMEGALY; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DRUG MECHANISM; HEART INFARCTION; HUMAN; HYPERTENSION; MORNING DOSAGE; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REM SLEEP; REVIEW; RISK REDUCTION; SEDATION; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP QUALITY; SLEEP TIME; STROKE; SUDDEN DEATH; SURGICAL TECHNIQUE; TREATMENT RESPONSE; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; CHOLINESTERASE INHIBITORS; HUMANS; RESPIRATORY SYSTEM AGENTS; RISK FACTORS; SEROTONIN AGENTS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84863390500     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2012.666525     Document Type: Review

References (105)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med 2002;165:1217-39
2. Krieger J. Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snorers. Sleep 1992;15(6 Suppl):S42-6
3. Lacassagne L, Didier A, Doussau S, et al. Results of 248 patients with sleep apnea syndrome treated by continuous positive pressure ventilation between 1990 and 1995. A study of compliance and outcome of the apnea-hypopnea index. Rev Mal Respir 2000;17:467-74
4. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: The challenge to effective treatment. Proc Am Thorac Soc 2008;5:173-8
5. Ferguson KA, Cartwright R, Rogers R, et al. Oral appliances for snoring and obstructive sleep apnea: A review. Sleep 2006;29:244-62
6. Kushida CA, Morgenthaler TI, Littner MR, et al. Practice parameters for the treatment of snoring and Obstructive Sleep Apnea with oral appliances: An update for 2005. Sleep 2006;29:240-3
7. Veasey SC, Guilleminault C, Strohl KP, et al. Medical therapy for obstructive sleep apnea: A review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006;29:1036-44 Official review article of sleep apnea medical therapy published by the American Sleep Society
8. Morgenthaler TI, Kapen S, Lee-Chiong T, et al. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep 2006;29:1031-5 Official practice guideline of sleep apnea medical therapy published by the American Sleep Society
9. Wellman A, Jordan AS, Malhotra A, et al. Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 2004;170:1225-32
10. Guilleminault C, Hayes B. Naloxone, theophylline, bromocriptine, and obstructive sleep apnea. Negative results. Bull Eur Physiopathol Respir 1983;19:632-4. Naloxoin, theophyllince and bromocriptine trials for sleep apnea
11. Orth MM, Grootoonk S, Duchna HW, et al. Short-term effects of oral theophylline in addition to CPAP in mild to moderate OSAS. Respir Med 2005;99:471-6
12. Atkinson RL, Suratt PM, Wilhoit SC, et al. Naloxone improves sleep apnea in obese humans. Int J Obes 1985;9:233-9
13. Greenberg HE, Rapoport DM, Rothenberg SA, et al. Endogenous opiates modulate the postapnea ventilatory response in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1991;143:1282-7
14. Benarroch EE. Brainstem respiratory control: Substrates of respiratory failure of multiple system atrophy. Mov Disord 2007;22:155-61. Brainstem respiratory control circuit help to explain opioid antagonist respiration effect
15. Guilleminault C, Cao M, Yue HJ, et al. Obstructive sleep apnea and chronic opioid use. Lung 2010;188:459-68. Explains why chronic opioid use will interfere with respiratory drive
16. Suratt PM, Wilhoit SC, Brown ED, et al. Effect of doxapram on obstructive sleep apnea. Bull Eur Physiopathol Respir 1986;22:127-31
17. Quitadamo C, Fabbretti E, Lamanauskas N, et al. Activation and desensitization of neuronal nicotinic receptors modulate glutamatergic transmission on neonatal rat hypoglossal motoneurons. Eur J Neurosci 2005;22:2723-34
18. Haxhiu MA, Van Lunteren E, Van de Graaff WB, et al. Action of nicotine on the respiratory activity of the diaphragm and genioglossus muscles and the nerves that innervate them. Respir Physiol 1984;57:153-69
19. Haxhiu MA, Deal EC Jr, Norcia MP, et al. Medullary effects of nicotine and GABA on tracheal smooth muscle tone. Respir Physiol 1986;64:351-63
20. Davila DG, Hurt RD, Offord KP, et al. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med 1994;150:469-74
21. Zevin S, Swed E, Cahan C. Clinical effects of locally delivered nicotine in obstructive sleep apnea syndrome. Am J Ther 2003;10:170-5
22. Chamberlin NL, Saper CB. Topographic organization of respiratory responses to glutamate microstimulation of the parabrachial nucleus in the rat. J Neurosci 1994;14:6500-10
23. Hedner J, Grunstein R, Eriksson B, et al. A double-blind, randomized trial of sabeluzole - A putative glutamate antagonist - in obstructive sleep apnea. Sleep 1996;19:287-9
24. Finnimore AJ, Roebuck M, Sajkov D, et al. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J 1995;8:230-4
25. Torvaldsson S, Grote L, Peker Y, et al. A randomized placebo-controlled trial of an NMDA receptor antagonist in sleep-disordered breathing. J Sleep Res 2005;14:149-55
26. Whyte KF, Gould GA, Airlie MA, et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988;11:463-72
27. Sakamoto T, Nakazawa Y, Hashizume Y, et al. Effects of acetazolamide on the sleep apnea syndrome and its therapeutic mechanism. Psychiatry Clin Neurosci 1995;49:59-64
28. Inoue Y, Takata K, Sakamoto I, et al. Clinical efficacy and indication of acetazolamide treatment on sleep apnea syndrome. Psychiatry Clin Neurosci 1999;53:321-2
29. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: A double-blind, prospective study. Am J Respir Crit Care Med 2006;173:234-7. This study showed that a carbonic anhydrase inhibitor improved central sleep apnea in heart failure
30. Nussbaumer-Ochsner Y, Latshang TD, Ulrich S, et al. Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: A randomized, placebo-controlled, double-blind trial. Chest 2012;141(1):131-38. Study showing that a carbonic anhydrase inhibitor improves sleep apnea during an altitude sojourn
31. Hedner J, Kraiczi H, Peker Y, et al. Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med 2003;168:1246-51. Acetylcholinesterate inhibitors improve apnea hypopnea index (AHI) especially during REM sleep and lead to human study
32. Moraes W, Poyares D, Sukys-Claudino L, et al. Donepezil improves obstructive sleep apnea in Alzheimer disease: A double-blind, placebo-controlled study. Chest 2008;133:677-83. This study showed that donepezil improves AHI and oxygen saturation during sleep in Alzheimer's patients
33. Susky-Soranos L, Moraes W, Guilleminault C, et al. Beneficial effect of donepezil on obstructive sleep apnea: A double blind placebo controlled clinical trial. Sleep medicine 2012;13(3):290-96. This s showed that donepezil improves sleep AHI, desaturation index and daytime sleepiness
34. Veasey SC. Serotonin agonists and antagonists in obstructive sleep apnea: Therapeutic potential. Am J Respir Med 2003;2:21-9. Revealed which 5-HT receptor subtypes have been explored
35. Veasey SC, Zhan G, Fenik P, et al. Long-term intermittent hypoxia: Reduced excitatory hypoglossal nerve output. Am J Respir Crit Care Med 2004;170:665-72
36. Kraiczi H, Hedner J, Dahlof P, et al. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 1999;22:61-7
37. Berry RB, Yamaura EM, Gill K, et al. Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep 1999;22:1087-92
38. Prasad B, Radulovacki M, Olopade C, et al. Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome. Sleep 2010;33:982-9
39. Brownell LG, Perez-Padilla R, West P, et al. The role of protriptyline in obstructive sleep apnea. Bull Eur Physiopathol Respir 1983;19:621-4
40. Smith PL, Haponik EF, Allen RP, et al. The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis 1983;127:8-13
41. Berry RB, Koch GL, Hayward LF. Low-dose mirtazapine increases genioglossus activity in the anesthetized rat. Sleep 2005;28:78-84
42. Castillo JL, Menendez P, Segovia L, et al. Effectiveness of mirtazapine in the treatment of sleep apnea/hypopnea syndrome (SAHS). Sleep Med 2004;5:507-8
43. Brunner H. Success and failure of mirtazapine as alternative treatment in elderly stroke patients with sleep apnea-A preliminary open trial. Sleep Breath 2008;12:281-5
44. Marshall NS, Yee BJ, Desai AV, et al. Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. Sleep 2008;31:824-31. Showed the side effects of mirtazapine and why it is not recommended for the treatment of obstructive sleep apnea (OSA)
45. Issa FG. Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis 1992;145:435-9
46. Pawlik MT, Hansen E, Waldhauser D, et al. Clonidine premedication in patients with sleep apnea syndrome: A randomized, double-blind, placebo-controlled study. Anesth Analg 2005;101:1374-80
47. Grunstein RR, Ho KY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med 1991;115:527-32
48. Weiss V, Sonka K, Pretl M, et al. Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest 2000;23:515-19
49. Mestron A, Webb SM, Astorga R, et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the spanish acromegaly registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 2004;151:439-46. Multicenter, epidemiological sleep apnea prevalence study in Spanish acromegaly patients
50. Herrmann BL, Wessendorf TE, Ajaj W, et al. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur J Endocrinol 2004;151:309-15
51. Ip MS, Tan KC, Peh WC, et al. Effect of Sandostatin LAR on sleep apnoea in acromegaly: Correlation with computerized tomographic cephalometry and hormonal activity. Clin Endocrinol (Oxf) 2001;55:477-83
52. Rosenow F, Reuter S, Deuss U, et al. Sleep apnoea in treated acromegaly: Relative frequency and predisposing factors. Clin Endocrinol (Oxf) 1996;45:563-9. Explains that one-fifth of treated acromegaly patients have persistent sleep apnea due to underlying craniofacial abnormality
53. Winkelman JW, Goldman H, Piscatelli N, et al. Are thyroid function tests necessary in patients with suspected sleep apnea? Sleep 1996;19:790-3. High prevalence of hypothyroidism in sleep apnea patients
54. Resta O, Pannacciulli N, Di Gioia G, et al. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis 2004;14:248-53. Shows a high prevalence of hypothyroidism in obese sleep apnea patients
55. Lin CC, Tsan KW, Chen PJ. The relationship between sleep apnea syndrome and hypothyroidism. Chest 1992;102:1663-7
56. Grunstein RR, Sullivan CE. Sleep apnea and hypothyroidism: Mechanisms and management. Am J Med 1988;85:775-9
57. Skjodt NM, Atkar R, Easton PA. Screening for hypothyroidism in sleep apnea. Am J Respir Crit Care Med 1999;160:732-5
58. Rowley JA, Zhou XS, Diamond MP, et al. The determinants of the apnea threshold during NREM sleep in normal subjects. Sleep 2006;29:95-103
59. Young T, Finn L, Austin D, et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003;167:1181-5 Longitudinal epidemiological study revealed odds ratio of sleep-disordered breathing in postmenopausal women
60. Pickett CK, Regensteiner JG, Woodard WD, et al. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 1989;66:1656-61
61. Keefe DL, Watson R, Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: A pilot study. Menopause 1999;6:196-200
62. Manber R, Kuo TF, Cataldo N, et al. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: A pilot study. Sleep 2003;26:163-8
63. Saletu-Zyhlarz G, Anderer P, Gruber G, et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: Sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 2003;12:239-54
64. Cistulli PA, Barnes DJ, Grunstein RR, et al. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994;49:699-702
65. Block AJ, Wynne JW, Boysen PG, et al. Menopause, medroxyprogesterone and breathing during sleep. Am J Med 1981;70:506-10
66. Polo-Kantola P, Rauhala E, Helenius H, et al. Breathing during sleep in menopause: A randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol 2003;102:68-75
67. Nelson HD, Humphrey LL, Nygren P, et al. Postmenopausal hormone replacement therapy: Scientific review. JAMA 2002;288:872-81. Found that risks of hormone replacement therapy outweigh their benefit, so it is not recommended in OSA management
68. Terra SG, Oberg KC. Medroxyprogesterone acetate in the treatment of obstructive sleep apnea. Ann Pharmacother 1997;31:776-8
69. Stewart DA, Grunstein RR, Berthon-Jones M, et al. Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnea. Am Rev Respir Dis 1992;146:1389-93
70. Gambineri A, Pelusi C, Pasquali R. Testosterone levels in obese male patients with obstructive sleep apnea syndrome: Relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. J Endocrinol Invest 2003;26:493-8
71. Liu PY, Yee B, Wishart SM, et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 2003;88:3605-13. Found that patients receiving testosterone should be monitored for sleep apnea
72. Canova CR, Downs SH, Knoblauch A, et al. Increased prevalence of perennial allergic rhinitis in patients with obstructive sleep apnea. Respiration 2004;71:138-43 Study showing a prevalence of allergic rhinitis in the sleep apnea population
73. Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax 2004;59:50-5
74. Alexopoulos EI, Kaditis AG, Kalampouka E, et al. Nasal corticosteroids for children with snoring. Pediatr Pulmonol 2004;38:161-7
75. Mansfield LE, Diaz G, Posey CR, et al. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol 2004;92:240-4
76. Goldbart AD, Goldman JL, Veling MC, et al. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 2005;172:364-70
77. Dayyat E, Serpero LD, Kheirandish-Gozal L, et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest 2009;135:1142-9
78. Kheirandish L, Goldbart AD, Gozal D. Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children. Pediatrics 2006;117:e61-6. Explains that combined anti-inflammatory therapy improves residual sleep apnea post-tonsillectomy and adenoidectomy surgery
79. Braver HM, Block AJ. Effect of nasal spray, positional therapy, and the combination thereof in the asymptomatic snorer. Sleep 1994;17:516-21
80. Guilleminault C, Philip P. Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment). Sleep 1996;19(9 Suppl):S117-22. Revealed residual sleepiness even after OSA treatment
81. Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007;30:711-19
82. Hedner J, Zou D. Pharmacological management of sleep-disordered breathing. In: McNicholas WT, Bonsignore MR, editors. Sleep Apnoea. 50 European Respiratory Monograph; UK: 2010. p. 321-39 The European regulatory agency has issued a recommendation to limit prescription of this compound in OSA patients suffering from residual sleepiness after continuous positive airway pressure (CPAP) treatment
83. Hirshkowitz M, Black JE, Wesnes K, et al. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med 2007;101:616-27
84. Roth T, White D, Schmidt-Nowara W, et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: A 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther 2006;28:689-706. Armodafinil treatment effects on post-CPAP residual sleepiness
85. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313-16. Plasma cytokine elevation induced excessive daytime sleepiness
86. Vgontzas AN, Zoumakis E, Lin HM, et al. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004;89:4409-13
87. Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006;58:87-114
88. El Solh AA, Saliba R, Bosinski T, et al. Allopurinol improves endothelial function in sleep apnoea: A randomised controlled study. Eur Respir J 2006;27:997-1002. Allopurinol improved endothelial function in sleep apnea
89. Grebe M, Eisele HJ, Weissmann N, et al. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006;173:897-901
90. Gonzaga CC, Gaddam KK, Ahmed MI, et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med 2010;6:363-8. Correlation between sleep apnea severity and plasma aldosterone concentration
91. Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: A preliminary report. J Hum Hypertens 2010;24:532-7
92. Ozol D, Turkay C, Kasapoglu B, et al. Relationship between components of metabolic syndrome and polysomnographic findings in obstructive sleep apnea. Metab Syndr Relat Disord 2011;9:13-18
93. Trombetta IC, Somers VK, Maki-Nunes C, et al. Consequences of comorbid sleep apnea in the metabolic syndrome - implications for cardiovascular risk. Sleep 2010;33:1193-9. Examines the increased cardiovascular risk of comorbid sleep apnea in metabolic syndrome patients
94. Lam JC, Mak JC, Ip MS. Obesity, obstructive sleep apnea and metabolic syndrome. Respirology 2011;17(2):223-36. Healthy diet and appropriate metabolic syndrome lifestyle modifications are equally important to CPAP treatment for sleep apnea pateints
95. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-21 Longitudinal study of strong linear correlation between obesity and OS.A.
96. Padwal R, Li SK, Lau DC. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev 2003;4:CD004094. Comparison study of two effective antiobesity medications
97. Camacho ME, Morin CM. The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea. Sleep 1995;18:644-5
98. Berry RB, Kouchi K, Bower J, et al. Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1995;151:450-4
99. Schneider H, Grote L, Peter JH, et al. The effect of triazolam and flunitrazepam - two benzodiazepines with different half-lives - on breathing during sleep. Chest 1996;109:909-15
100. Abad VC, Guilleminault C. Pharmacological treatment of obstructive sleep apnea. Curr Pharm Des 2011;17:1418-25 Outline of this pharmacotherapy review
101. Farney RJ, Walker JM, Cloward TV, et al. Sleep-disordered breathing associated with long-term opioid therapy. Chest 2003;123:632-9
102. Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest 2005;128:1348-56. Central sleep apnea needs to be monitored in long-term methadone maintenance therapy
103. Gross JB, Bachenberg KL, Benumof JL, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: A report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2006;104(5):1081-93 Official American Anesthersiologists Society practice guidelines for perioperative management of sleep apnea patients
104. Chung SA, Yuan H, Chung F. A systemic review of obstructive sleep apnea and its implications for anesthesiologists. Anesth Analg 2008;107:1543-63 Official review of sleep apnea care for anesthesiologists
105. Schwengel DA, Sterni LM, Tunkel DE, et al. Perioperative management of children with obstructive sleep apnea. Anesth Analg 2009;109:60-75 Official review of pediatric sleep apnea care for anesthesiologists.